4.3 Review

L1 cell adhesion molecule as a therapeutic target in cancer

Journal

EXPERT REVIEW OF ANTICANCER THERAPY
Volume 16, Issue 3, Pages 359-371

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.2016.1143363

Keywords

cancer therapy; signal pathway; cell migration; prognostic marker; L1 cell adhesion molecule

Categories

Funding

  1. National Natural Science Foundation of China [81201896, 81071884]
  2. National Health and Planning Commission of the PRC on General Surgery
  3. National Health and Planning Commission of the PRC on Oncology
  4. Research Fund for the Doctoral Program of Higher Education of China [20130071110052, 20110071110065]

Ask authors/readers for more resources

L1 cell adhesion molecule (L1CAM) is the prototype member of the L1-family of closely related neural adhesion molecules. L1CAM is differentially expressed in the normal nervous system as well as pathological tissues and displays a wide range of biological activities. In human malignancies, L1CAM plays a vital role in tumor growth, invasion and metastasis. Recently, increasing evidence has suggested that L1CAM exerts a variety of functions at different steps of tumor progression through a series of signaling pathways. In addition, L1CAM has been identified as a promising target for cancer therapy by using synthetic and natural inhibitors. In this review, we provide an up-to-date overview of the role of L1CAM involved in cancers and the rationale for L1CAM as a novel molecular target for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available